COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
The Food and Drug Administration released a briefing document on Pfizer’s BNT162b2 COVID-19 vaccine candidate that confirms the drug maker’s claims of the vaccine’s efficacy and safety.
The Centers for Disease Control and Prevention has published an addenda with instructions for implementing six new ICD-10 diagnosis codes for reporting COVID-19-related conditions on health care claims effective Jan. 1.
FDA issues COVID-19 policies on clinical trials for medical products, mammography quality standards.
The Food and Drug Administration Dec. 4 issued guidance on how to conduct clinical trials for medical products during the COVID-19 public health emergency.
The Centers for Medicare & Medicaid Services has identified the Healthcare Common Procedural Coding System codes and Medicare Part B payment allowances effective Nov. 21 for administering casirivimab and imdevimab, a combination monoclonal antibody therapy made by Regeneron.
The AHA will host two important calls for hospital and health system leaders on issues related to the COVID-19 pandemic.
The FDA this week revised and reissued its August emergency use authorization for COVID-19 convalescent plasma to treat hospitalized patients with COVID-19. The revised EUA adds the Mount Sinai COVID-19 ELISA IgG Antibody Test as an acceptable test for qualifying high and low titer COVID-19…
The Centers for Disease Control and Prevention announced shorter quarantine options based on local circumstances and resources, for people exposed to the COVID-19 virus.
An independent advisory group for the Centers for Disease Control and Prevention recommended health care personnel and long-term care facility residents receive vaccinations against COVID-19 in the program’s initial phase.
The AHA asks the Department of Health and Human Services (HHS) to take additional steps to increase flexibilities for providers responding to the COVID-19 pandemic.
A new report from the Centers for Disease Control and Prevention looks at an outbreak of Carbapenem-resistant Acinetobacter baumannii (CRAB), an antibiotic-resistant bacteria, at a New Jersey hospital managing resource shortages during a surge in COVID-19 patients.